HOUSTON, Apr 27, 2005 (BUSINESS WIRE) -- Botaniex, Inc. (BTXI: Pink Sheets), announced today that it has appointed Jacking (Jianqing) Zeng as Chief Operating Officer of the Company.
Jacking Zeng brings to Botaniex, Inc. a wealth of experience in research and development, technical innovation, manufacturing and quality control of botanical/herbal ingredients. In particular, his expertise in Super Critical Fluid Extraction (SCFE) provides a unique competitive advantage to Botaniex. Mr. Zeng holds the rights to several patent-pending products and has developed over 80 types of herbal ingredients, which add significant asset value to Botaniex Inc.
Prior to joining Botaniex, Mr. Zeng was Technology Director of Shanghai Novanat Bio-Resources Co. Ltd, and oversaw the operation of two plants; focusing on new product development, improvement/innovation of manufacturing processes and establishment of quality control systems. He was also responsible for the selection and evaluation of outsourcing partners with a view towards capacity expansion and cost reduction. Before joining Novanat, Mr. Zeng held the position of Vice President of the Botanical Extracts Division of Qingdao Yizhong SunStar Co., Ltd. where he developed several innovative ingredients with the advanced extraction technology using carbon dioxide (SCFE). These ingredients are very popular because they are of high purity, residue-free, safe and of high efficacy.
Prior to his tenure at Yizhong SunStar, in 2000 Mr. Zeng was Professor of Guangzhou Institute of Chemistry/China Academy of Science, where he was awarded with the Title of Outstanding Youth and The Prize of ScienTech Improvement. In 2001, he performed research on Super Critical Fluid Extraction with Carbon Dioxide, as a Senior Visiting Scholar to the University of Tokyo, Japan and his achievements were highly recognized by the university. In addition, Mr. Zeng has published over 50 essays and articles on the extraction and development of herbal ingredients, which were featured in several reputable magazines in China. In particular, he co-authored one of the most influential books in the botanical extraction field entitled, "Technology of Super Critical Fluid Extraction and its Applications." Mr. Zeng received a Bachelor of Science from Hunan Normal University, MS, and a PhD in Chemistry from China Academy of Science.
CEO Melson Liao stated: "I am proud to welcome Mr. Zeng to Botaniex Inc. We are now in a stronger position to develop innovative ingredients that will enable us to seize a larger market share of the multi-billion dollar herbal ingredients industry. We are confident that with Mr. Zeng's expertise and technology Botaniex can achieve its financial and strategic goals for the coming years."
About Botaniex Inc.
Botaniex Inc. is an innovative manufacturer of botanical/herbal extracts, serving the worldwide manufacturers of dietary supplements, health foods, functional beverage, pharmaceuticals and cosmetics. The Company's product line is broad, ranging from tea and herbal extracts to essential oils. Botaniex not only provides customized ingredients, but also offers value-added services such as formulation assistance, clinical trial support and private label manufacturing. The Company is in the process of expanding its operations, including its client and asset-base, in Asia and overseas. Botaniex's goal is to become a major player in the multi-billion dollar global herbal products industry.
Please be advised that statements made herein, other than historical data, constitute forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those stated or implied by such forward-looking statements. The potential risks and uncertainties include, among others, potential volatility in the company's stock price, increased competition, customer acceptance of new products and services offered by the company, and uncertainty of future revenue and profitability and fluctuations in its quarterly operating results. Please also be advised that the company's stock is not currently registered with the Securities and Exchange Commission.